Combining radiofrequency microneedling and thulium laser for aging skin treatment
RFMN in Combination With 1927 nm Thulium Laser for Treating Photoaged Skin: a Prospective, Controlled Study
This study tests if combining radiofrequency microneedling with a thulium laser can improve the appearance of aging skin for people with wrinkles and sagging.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 35 (estimated) |
| Ages | 30 Years and up |
| Sex | All |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf Academic / other |
| Locations | 1 site (Hamburg) |
| Trial ID | NCT06029725 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness and safety of combining radiofrequency microneedling (RFMN) with a 1927 nm thulium laser to treat photoaged skin. The study focuses on patients experiencing facial skin laxity, wrinkles, and pigmented lesions. Participants will receive either the combined treatment or RFMN alone, with assessments on efficacy and patient satisfaction. The goal is to provide a comprehensive evaluation of this combined approach in improving skin appearance.
Who should consider this trial
Good fit: Ideal candidates are men and women aged 30 and older with signs of facial aging such as wrinkles and pigmentation issues.
Not a fit: Patients under 30, pregnant or breastfeeding women, and those with significant facial scarring or certain medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the appearance of photoaged skin, enhancing patient satisfaction and quality of life.
How similar studies have performed: Previous studies have shown promising results with similar combined approaches in treating photoaging, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women from the age of 30 years * good general condition, no relevant previous diseases * Presence of wrinkles, dermatochalasis on the face, pigment spots, which are an indication for RFMN and thulium laser or comparable methods * Cognitive ability and willingness to give consent (informed consent) * Be willing and able to attend follow-up visits Exclusion Criteria: * Age \< 30 years * Pregnancy or breastfeeding * Excessive subcutaneous fatty tissue under the cheeks * Significant scarring of the region to be treated * open wounds or lesions of the region to be treated * Severe or cystic facial acne * Metallic implants in the face or neck region * Mental illnesses (psychoses, body perception disorders) * Use of isotretinoin or other retinoids, psychotropic drugs, coumarins or heparins in the last 2 weeks * Fillers in the region to be treated \< 4 weeks prior and during the study period * Resurfacing (fractional, ablative, nonablative) of the region of interest \< 2 months prior and during the study period * Plastic aesthetic procedures or other surgical procedures \< 6 months prior and during the study period * Tendency to have excessive scarring * Lack of informed consent
Where this trial is running
Hamburg
- University Medical Center Hamburg-Eppendorf — Hamburg, Germany (Recruiting)
Study contacts
- Study coordinator: L Nguyen
- Email: l.nguyen@uke.de
- Phone: +49
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.